Flumil

Flumil is a pharmaceutical product primarily used as a mucolytic agent to reduce the viscosity of mucus in the respiratory tract. The active ingredient in Flumil is acetylcysteine, which is commonly utilized in treatments for respiratory conditions. The product is marketed under various brand names in different countries, including Fluimucil in Italy and Fluimucil in the United States. The manufacturing and distribution rights for Flumil are held by Zambon S.p.A., an Italian pharmaceutical company specializing in respiratory and rare diseases. Zambon S.p.A. is headquartered in Bresso, Italy, and operates globally, with subsidiaries and partnerships in multiple countries to distribute its products.